ArriVent BioPharma, Inc. Common Stock (NASDAQ: AVBP) last traded at $16.09, down 2.25% on the session. The quote above updates while this page is open; the figures below are drawn from ArriVent BioPharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
ArriVent BioPharma, Inc. Common Stock trades on NASDAQ under the ticker AVBP. Its market capitalisation is $793.36 million.
Valuation measures for ArriVent BioPharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $793.36M |
|---|---|
| Enterprise value | $666.56M |
| Price / book | 2.16 |
| Beta | 1.04 |
Trailing-twelve-month figures tagged in ArriVent BioPharma, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$163.74M |
| EPS (TTM) | -$3.53 |
|---|
| Return on equity | -44.63% |
|---|
| Cash | $154.68M |
|---|
Range and volume for AVBP over the past 52 weeks.
| 52-week high | $35.83 |
|---|---|
| 52-week low | $11.36 |
| Volume | 1.97M |
| Average volume | 960.3K |
| Previous close | $16.46 |
Invest a chosen dollar amount in ArriVent BioPharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AVBP.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.